Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs
Molecular Genetics & Genomic Medicine · 2025
DOI: 10.1002/mgg3.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Elisabeth M Oehrlein und 8 weiteren Autor:innen. Beteiligte Einrichtung: Applied Patient Experience, LLC, Washington, DC, USA. Hauptthemen laut MEDLINE: Dwarfism, Lordosis, Limb Deformities, Congenital, Caregivers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioMarin Pharmaceutical Inc., BioMarin Pharmaceutical.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Hypochondroplasia (HCH) is a rare genetic skeletal dysplasia characterized by short stature, disproportionate limbs, and complications such as learning differences. Currently, no treatments are approved to address HCH‐related short stature, which can adversely affect quality of life. This study aimed to explore diagnostic processes, care pathways, daily life impacts, and unmet needs in HCH.
Methods
Ninety‐minute interviews were conducted with nine children and young adults and 25 caregivers who had physician‐confirmed HCH. Participants discussed diagnostic journeys, treatment considerations, and day‐to‐day challenges. Following interviews, two 90‐min focus groups among caregivers ( n = 10) were conducted to explore themes emerging during interviews.
Results
We found that diagnostic pathways vary significantly, with signs of HCH identified in utero or during infancy or early childhood. Families described complex psychosocial burdens that include impacts on daily activities and emotional challenges due to height differences and disproportionate limb length. Additionally, many people with HCH have complications that go beyond short stature and include developmental delays, learning differences, and seizures. Families desire more support and resources related to HCH.
Conclusion
Future efforts should focus on holistic, patient‐centered strategies to better support individuals with HCH and their families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Applied Patient Experience, LLC, Washington, DC, USA.
- Hypochondroplasia Families Community, Greystones, Ireland.
- BioMarin Pharmaceutical Inc., Novato, California, USA.
- The Chandler Project, Little Rock, Arkansas, USA.
- Children's National Hospital, Washington, DC, USA.
ORCID-Profile: Elisabeth M Oehrlein
Förderung
- BioMarin Pharmaceutical Inc.
- BioMarin Pharmaceutical
Zitieren
APA
Oehrlein, E. M., Pekala, R., Cavallaro, S., Cho, M., Crews, C., Dauber, A., Saxena, A., Vandigo, J., & Reese, E. S. (2025). Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70151
Vancouver
Oehrlein EM, Pekala R, Cavallaro S, Cho M, Crews C, Dauber A, et al. Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70151
BibTeX
@article{Oehrlein2025,
author = {Oehrlein, Elisabeth M and Pekala, Reni and Cavallaro, Stacie and Cho, Margaret and Crews, Chandler and Dauber, Andrew and Saxena, Ankita and Vandigo, Joe and Reese, Emily S},
title = {Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs},
journal = {Molecular Genetics & Genomic Medicine},
year = {2025},
doi = {10.1002/mgg3.70151}
}
EUVIMED